HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of standard coronary artery bypass grafting and minimary invasive direct coronary artery bypass grafting. Early and mid-term result.

AbstractOBJECTIVES:
We studied indications and problems involved in minimally invasive coronary artery bypass grafting (MIDCAB).
METHODS:
We compared patients profiles, graft patency, stenosis severity, morbidity, mortality, long-term survival and freedom from cardiac accidents in 174 patients undergoing elective standard coronary artery bypass grafting (CABG) and 128 undergoing between January 1996 and March 1999.
RESULTS:
No statistically difference was seen in gender, diabetes mellitus, renal failure, cerebrovascular accident, multi-vessel disease ratios, or left main trunk stenosis between 2 groups. Internal thoracic artery graft patency was 97% (114/118) and the rate of anastomotic stenosis (> 50%) was 9% (10/118) compared to 96% (213/221) in the MIDCAB group. The 3-year survival rate was 91% in the MIDCAB group and 92% in the CABG group and freedom from cardiac accidents, most involving pericutaneus transluminal coronary angioplasty retreatment, was 66% in the MIDCAB group and 88% in the CABG group.
CONCLUSION:
Although patency and stenosis incidence did not differ between 2 groups, freedom from cardiac accidents was lower in the MIDCAB group.
AuthorsY Okawa, H Baba, M Hashimoto, T Tanaka, M Toyama, K Matsumoto, K Azuma
JournalThe Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi (Jpn J Thorac Cardiovasc Surg) Vol. 48 Issue 11 Pg. 725-9 (Nov 2000) ISSN: 1344-4964 [Print] Japan
PMID11144093 (Publication Type: Comparative Study, Journal Article)
Topics
  • Aged
  • Aged, 80 and over
  • Angioplasty, Balloon, Coronary
  • Coronary Artery Bypass (standards)
  • Coronary Disease (surgery)
  • Female
  • Graft Occlusion, Vascular (etiology)
  • Humans
  • Male
  • Middle Aged
  • Minimally Invasive Surgical Procedures (methods)
  • Treatment Outcome
  • Vascular Patency

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: